BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17296523)

  • 1. Porphyria cutanea tarda.
    Yachimski P; Shah N; Chung RT
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):e6. PubMed ID: 17296523
    [No Abstract]   [Full Text] [Related]  

  • 2. [Porphyria cutanea tarda, hemodialysis and HCV hepatopathy].
    Muray S; Casanova JM; Marco MP; Craver L; Martín M; Fernández E
    Nefrologia; 2002; 22(6):570-3. PubMed ID: 12516291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Images in clinical medicine: Porphyria cutanea tarda.
    Chan CC; Lin SJ
    N Engl J Med; 2011 Sep; 365(12):1128. PubMed ID: 21992125
    [No Abstract]   [Full Text] [Related]  

  • 4. The additive effects of hepatitis C infection and end-stage renal disease in porphyria cutanea tarda.
    Chan OT; Tsai N; Wong RL; Izumi AK
    Cutis; 2006 Dec; 78(6):397-400. PubMed ID: 17243426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden.
    Linde Y; Harper P; Floderus Y; Ros AM
    Acta Derm Venereol; 2005; 85(2):164-6. PubMed ID: 15823914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porphyria cutanea tarda occurring in a patient with renal failure, systemic lupus erythematosus and chronic hepatitis C infection treated with hemodialysis.
    Lee PK; Abrahams I; Bickers DR
    Cutis; 1999 Oct; 64(4):237-9. PubMed ID: 10544877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case for diagnosis. Sclerodermiform manifestations of porphyria cutanea tarda secondary to hepatitis C.
    Calado JOA; Bastos LMH; Miot HA
    An Bras Dermatol; 2019; 94(4):479-481. PubMed ID: 31644627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for porphyria cutanea tarda -the iron/HFE connection.
    Bonkovsky HL;
    Liver Int; 2013 Jan; 33(1):162. PubMed ID: 23121614
    [No Abstract]   [Full Text] [Related]  

  • 9. Porphyria cutanea tarda in the Basque Country: significance of HFE gene mutations and of external factors.
    Castiella A; Zapata E; Otazua P; Zubiaurre L
    Liver Int; 2012 Nov; 32(10):1597. PubMed ID: 22680055
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic hepatitis C with extrahepatic manifestations.
    Poantă L; Albu A
    Rom J Intern Med; 2007; 45(1):85-8. PubMed ID: 17966447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum lipoproteins in patients with porphyria cutanea tarda].
    Fernández-Miranda C; de la Calle M; Gómez Izquierdo MT; Larumbe S; Enríquez de Salamanca R
    Med Clin (Barc); 1999 May; 112(17):656-7. PubMed ID: 10374187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of hepatitis C virus infection in Japanese patients with porphyria cutanea tarda.
    Kondo M; Horie Y; Okano J; Kitamura A; Maeda N; Kawasaki H; Mishiro S; Yamamoto S; Itou T; Saeki S; Tanaka S; Okamoto H
    Hepatology; 1997 Jul; 26(1):246. PubMed ID: 9214482
    [No Abstract]   [Full Text] [Related]  

  • 13. Skin lesions in a patient on therapy for chronic hepatitis C.
    Hisamuddin K; Veluru C; Mullen KD
    Clin Gastroenterol Hepatol; 2009 Jun; 7(6):A24. PubMed ID: 19166978
    [No Abstract]   [Full Text] [Related]  

  • 14. [Porphyria cutanea tarda as extrahepatic manifestation of chronic hepatitis C: a case report].
    Espinoza-Ríos J; Valenzuela Granados V; Ojeda Cisneros M; Gálvez Canseco A; Ramos Aguilar C; Raymundo Villalva B; Aguilar Sánchez V; Pinto Valdivia J; Huerta-Mercado Tenorio J; Bussalleu Rivera A
    Rev Gastroenterol Peru; 2017; 37(4):394-398. PubMed ID: 29459814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus and the skin.
    Al-Ali J; Al-Mutari N; Ahmed el-SF
    Hepatogastroenterology; 2011; 58(107-108):880-6. PubMed ID: 21830409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyria cutanea tarda in a hemodialysis patient with hepatitis C virus: efficacy of treatment with multiple phlebotomies and erythropoietin.
    Hamzi MA; Alayoud A; Asseraji M; Akhmouch I; Oualim Z
    Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):121-3. PubMed ID: 23354206
    [No Abstract]   [Full Text] [Related]  

  • 17. A blistering rash.
    Adejumo AA; Mannheimer SB
    Am J Med; 2010 Apr; 123(4):317-9. PubMed ID: 20362750
    [No Abstract]   [Full Text] [Related]  

  • 18. Type of impaired porphyrin metabolism caused by hepatitis C virus is not porphyria cutanea tarda but chronic hepatic porphyria.
    Gomi H; Hatanaka K; Miura T; Matsuo I
    Arch Dermatol; 1997 Sep; 133(9):1170-1. PubMed ID: 9301601
    [No Abstract]   [Full Text] [Related]  

  • 19. Extensive calcifications of the scalp in a patient with porphyria cutanea tarda secondary to hepatitis C virus infection.
    Rey J; Hesse S; Bonerandi JJ
    J Eur Acad Dermatol Venereol; 2007 Feb; 21(2):286-7. PubMed ID: 17243990
    [No Abstract]   [Full Text] [Related]  

  • 20. Porphyria cutanea tarda in a dialyzed patient with hepatitis C virus infection: dramatic efficacy of small repeated phlebotomies.
    Poux JM; Demontis R; Cadranel JF; Ghazali A; Fievet P; Nordmann Y
    Am J Med; 1997 Aug; 103(2):163-4. PubMed ID: 9274900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.